The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

ROS1-dependent cancers — biology, diagnostics and therapeutics

Clinical application of the AMOY 9-in-1 panel to lung cancer patients - ScienceDirect

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

肺癌靶点研究渐露锋芒，源井生物基因编辑细胞助力肿瘤研究_源井生物

IJMS, Free Full-Text

Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer

Division of Cancer Immunology

PDF) Matched Analyses of Brain Metastases versus Primary Non-Small Cell Lung Cancer Reveal a Unique microRNA Signature

Frequency of driver mutations in lung adenocarcinoma A. and lung

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

Comparison of ALK and LTK structure and sequence. (A) Schematic of

PDF] Recent Progress in Rare Oncogenic Drivers and Targeted Therapy For Non-Small Cell Lung Cancer

Frontiers Recent progress in targeted therapy for non-small cell lung cancer